참고문헌 (39)

1. Int. J. Cancer T. Abe 58 860 1994 10.1002/ijc.2910580619 Abe, T., Hasegawa, S., Taniguchi, K., Yokomizo, A., Kuwano, T., Ono, M., Mori, T., Hori, S., Kohno, K. and Kuwano, M., Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells.Int. J. Cancer, 58, 860-864, (1994). 

   상세보기

2. J. Clin. Invest. S. Awashi 93 958 1994 10.1172/JCI117102 Awashi, S., Singhai, S. S., Srivastava, S. K., Zimniak, P., Bajpai, K. K., Saxena, M., Sharma, R., Ziller III, S. A., Frenkel, E. P., Singh, S. V., He, N. G. and Awashi, Y. C., Adenosin triphosphate-dependent transport of doxorubicin, daunomycin and vinblastine in human tissues by a mechanism distinct from the P-glycoprotein.J. Clin. Invest., 93, 958-965 (1994). 

   상세보기

3. Biochim. Biophys. Acta G. Bradley 948 87 1988 Bradley, G., Juranka, P. F. and Ling, V., Mechanism of multidrug resistance.Biochim. Biophys. Acta, 948, 87-128 (1988). 

4. Biochim. Biophys. Acta R. Callaghan 1175 277 1993 10.1016/0167-4889(93)90217-D Callaghan, R., Zakher, G. and Epand, R., Increased accumulation of drugs in a multidrug resistant cell line by alteration of membrane biophysical properties.Biochim. Biophys. Acta, 1175, 277-282 (1993). 

   상세보기

5. Cancer Res. G. Chen 54 4980 1994 Chen, G., Jaffrzou, J. P., Fleming, W. H., Durn, G. E. and Sikic, B. I., Prevalence of multidrug resistance related to activation of themdr gene in human sarcoma mutants derived by single-step doxorubicin selection.Cancer Res., 54, 4980-4987 (1994). 

   상세보기

6. Annu. Rev. Pharmacol. Toxicol. G. L. Chen 34 191 1994 10.1146/annurev.pa.34.040194.001203 Chen, G. L. and Liu, L. F., DNA topoisomerases: essential enzymes and lethal targets.Annu. Rev. Pharmacol. Toxicol., 34, 191-218 (1994). 

   상세보기

7. Br. J. Cancer S. P. C. Cole 65 498 1992 10.1038/bjc.1992.103 Cole, S. P. C., Pinkoski, M. J., Bhardwaj, G. and Deeley, R. G., Elevated expression of Annexin II (Lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line.Br. J. Cancer, 65, 498-502 (1992). 

   상세보기

8. J. Biol. Chem. M. M. Cornwell 261 7921 1986 10.1016/S0021-9258(19)57491-9 Cornwell, M. M., Gottesman, M. M. and Pastan, I. H., Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells.J. Biol. Chem., 261, 7921-7928 (1986). 

   상세보기

9. Biochem. Pharmacol. J. W. Critchfield 48 1437 1994 10.1016/0006-2952(94)90568-1 Critchfield, J. W., Welsh, C. J., Phang, J. M. and Yeh, G. C., Modulation of adriamycin and efflux by flavonoids in HCT15 colon cells.Biochem. Pharmacol., 48, 1437-1445 (1994). 

   상세보기

10. Oncol. Res. B. Damle 6 49 1994 Damle, B. and Desai, P., Dipyridamole reverses the resistance to topoisomerase II inhibitors but not to antimicrotubule agents in multidrug-resistant melanoma cells.Oncol. Res., 6, 49-57 (1994). 

    상세보기

11. Int. J. Cancer M. T. Dimanche-Boitrel 50 667 1992 10.1002/ijc.2910500502 Dimanche-Boitrel, M. T., Pelletier, H., Genne, P., Petit, J. M., Le Grimellec, C., Canal P., Ardiet, C., Bastian, G. and Chauffert, B., Confluence-dependent resistance in human colon cancer cells; role of reduced drug accumulation and low intrinsic chemosensitivity of resting cells.Int. J. Cancer, 50, 667-682 (1992). 

    상세보기

12. Br. J. Cancer L. A. Doyle 71 52 1995 10.1038/bjc.1995.11 Doyle, L. A., Ross, D. D., Sridhara, R., Fojo, A. T., Kaufmann, S. H., Lee, E. J. and Schiffer, C. A., Expression of a 95 kDa membrane protein is associated with low daunorubicin accumulation in leukaemic blast cells.Br. J. Cancer, 71, 52-58 (1995). 

    상세보기

13. Br. J. Cancer E. W. H. M. Eijdems 71 40 1995 10.1038/bjc.1995.9 Eijdems, E. W. H. M., de Haas, M., Timmerman, A. J., Van der Sohans, G. P., Kamst, E., de Nooij, J., Astaldi Ricotti, G. C. B., Borst, P. and Baas, F., Reduced topoisomerase II activity in multidrug-resistant human non-small cell lung cancer cell lines.Br. J. Cancer, 71, 40-47 (1995). 

    상세보기

14. Proc. Natl. Acad. Sci. USA A. T. Fojo 84 265 1987 10.1073/pnas.84.1.265 Fojo, A. T., Ueda, K., Slaman, D. J., Poplack, D. G., Gottesman, M. M. and Pastan, I., Expression of a multidrug-resistance gene in human tumors and tissues.Proc. Natl. Acad. Sci. USA, 84, 265-269 (1987). 

    상세보기

15. Cancer Res. A. Fry 51 6592 1991 Fry, A., Chrest, C., Davies, S., Walker, C., Harris, A., Hartley, J., Masters, J. and Hickson, I., Relationship between topoisomerase II level and chemosensitivity in human tumor cell lines.Cancer Res., 51, 6592-6595 (1991). 

    상세보기

16. Jpn. J. Cancer Res. E. Gheuens 84 1201 1993 10.1111/j.1349-7006.1993.tb02822.x Gheuens, E., van der Heyden, S., Elst, H., Eggermont, A., Oosterom, A. V. and De Bruijn E., Multidrug resistance in rat colon carcinoma cell lines CC531, CC531mdr+ and CC531rev.Jpn. J. Cancer Res., 84, 1201-1208 (1993). 

    상세보기

17. Anticancer Res. T. Iwahashi 11 1309 1991 Iwahashi, T., Okochi, E., Ono, K., Sugawara, I., Tsuruo, T. and Mori, S., Establishment of multidrug resistant human colorectal carcinoma HCT15 cell lines and their properties.Anticancer Res., 11, 1309-1312 (1991). 

    상세보기

18. FASEB J. P. F. Juranka 3 2583 1989 10.1096/fasebj.3.14.2574119 Juranka, P. F., Zastawny, R. L. and Ling, V., P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins.FASEB J., 3, 2583-2592 (1989). 

    상세보기

19. Science N. Kartner 221 1285 1983 10.1126/science.6137059 Kartner, N., Riordan, J. R. and Ling, V., Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines.Science, 221, 1285-1288 (1983). 

    상세보기

20. Cancer Res. W.D. Klohs 48 3025 1988 Klohs, W.D. and Steinkampf, R. W., Possible link between the intrinsic drug resistance of colon tumors and a detoxification mechanism of interstinal cells.Cancer Res., 48, 3025-3030 (1988). 

    상세보기

21. Science R. Kramer 241 694 1988 10.1126/science.3399900 Kramer, R., Zakher, G. and Kim, J., Role of the glutathione redox cycle in acquired andde novo multidrug resistance.Science, 241, 694-697 (1988). 

    상세보기

22. Int. J. Cancer G. M. Lai 49 696 1991 10.1002/ijc.2910490512 Lai, G. M., Chen, Y. N., Mickley, L. A., Fojo, A. T. and Bates, S. E., P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma.Int. J. Cancer, 49, 696-703 (1991a). 

    상세보기

23. Int. J. Cancer. G. M. Lai 49 688 1991 10.1002/ijc.2910490511 Lai, G. M., Moscow, J. A., Alvarez, M. G., Fojo, A. T. and Bates, S. E., Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines.Int. J. Cancer., 49, 688-695 (1991b). 

    상세보기

24. Cancer Res. S. A. Lee 52 3750 1992 Lee, S. A., Karaszkiewicz, J. W. and Anderson, W. B., Elevated level of nuclear protein kinase C in multidrug-resistant MCF-7 human breast carcinoma cells.Cancer Res., 52, 3750-3759 (1992). 

    상세보기

25. Anticancer Drug Des. R. Lock 2 151 1987 Lock, R. and Ross, W., DNA topoisomerases in cancer therapy. AnticancerDrug Des., 2, 151-164 (1987). 

    상세보기

26. J. Biol. Chem. L. A. Mickley 264 18031 1989 10.1016/S0021-9258(19)84675-6 Mickley, L. A., Bates, S. E., Richert, N. D., Currier, S., Tanaka, S., Foss, F., Rosen, N. and Fojo, A. T., Modulation of the expression of a multidrug resistance gene (mdr-1/Pglycoprotein) by differentiating agents.J. Biol. Chem., 264, 18031-18040 (1989). 

    상세보기

27. Cancer Res. M. Naito 49 1452 1989 Naito, M. and Tsuruo, T., Competitive inhibition by verapamil of ATP-dependent high-affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium-ion involvement.Cancer Res., 49, 1452-1455 (1989). 

    상세보기

28. Mol. Pharmacol. J. L. Nitiss 46 773 1994 Nitiss, J. L., Vilalta, P. M., Wu, H. and McMahon, J., Mutations in the gyrB domain of eukaryotic topoisomerase II can lead to partially dominant resistance to etoposide and amsacrine.Mol. Pharmacol., 46, 773-777 (1994). 

    상세보기

29. J. Natl. Cancer Inst. J. G. Park 86 700 1994 10.1093/jnci/86.9.700 Park, J. G., Lee, S. K., Hong, I. G., Kim, H. S., Lim, K. H., Choe, K. J., Kim, W. H., Kim, Y. I., Tsuruo, T. and Gottesman, M. M., MDR1 gene expression: its effects on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines.J. Natl. Cancer Inst., 86, 700-705 (1994). 

    상세보기

30. Arch. Pharm. Res. S. Y. Ryu 15 356 1992 10.1007/BF02974112 Ryu, S. Y., Choi, S. U., Lee, C. O. and Zee, O. P., Anticancer activity ofPsoralea corylifolia.Arch. Pharm. Res., 15, 356-359 (1992). 

    원문보기 상세보기

31. J. Natl. Cancer. Inst. P. Skehan 82 1107 1990 10.1093/jnci/82.13.1107 Skehan, P., Streng, R., SCudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S. and Boyd, M.R., New colorimetric cytotoxicity assay for anticancer-drug screening.J. Natl. Cancer. Inst., 82, 1107-1112 (1990). 

    상세보기

32. J. Natl. Cancer Inst. W. A. F. Tompkins 52 1101 1974 10.1093/jnci/52.4.1101 Tompkins, W. A. F., Watrach, A. M., Schmale, J. D., Schultz, R. M. and Harris, J. A., Cultural and antigenic properties of newly established cell strains derived from adenocarcinomas of the human colon and rectum.J. Natl. Cancer Inst., 52, 1101-1110 (1974). 

    상세보기

33. Cancer Treat. Rep. T. Tsuruo 67 889 1983 Tsuruo, T., Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics.Cancer Treat. Rep., 67, 889-894 (1983). 

    상세보기

34. Cancer Res. T. Tsuruo 41 1967 1981 Tsuruo, T., Iida, H., Tsukayoshi, S. and Sukarai, Y., Overcoming of vincristine-resistance in P388 leukemiain vivo andin vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.Cancer Res., 41, 1967-1972 (1981). 

    상세보기

35. Free Rad. Biol. Med. M. Turner 9 415 1990 10.1016/0891-5849(90)90018-E Turner, M., Everman, D., Ellington, S. and Fields, C., Detection of free radicals during the cellular metabolism of adriamycin.Free Rad. Biol. Med., 9, 415-421 (1990). 

    상세보기

36. Proc. Natl. Acad. Sci. USA K. Ueda 84 3004 1987 10.1073/pnas.84.9.3004 Ueda, K., Cardarelli, C., Gottesman, M. M. and Pastan, I., Expression of a full-length cDNA for the human “MDR1” gene confers resistance to colchicine, doxorubicin and vinblastin.Proc. Natl. Acad. Sci. USA, 84, 3004-3008 (1987). 

    상세보기

37. Annu. Rev. Biochem. J. C. Wang 54 665 1985 10.1146/annurev.bi.54.070185.003313 Wang, J. C., DNA topoisomerases.Annu. Rev. Biochem., 54, 665-697 (1985). 

    상세보기

38. Cancer Chemother. Pharmacol. R. Weiss 18 185 1986 10.1007/BF00273384 Weiss, R., Sarory, G., Clagett-Carr, K., Russo, M. and Leyland-Jones, B., Anthracycline analogues: the past, present, and future.Cancer Chemother. Pharmacol., 18, 185-197 (1986). 

    상세보기

39. Anticancer Drug Des. F. Zunino 5 30 1990 Zunino, F. and Capramco, G., DNA topoisomerase II as the primary target of anti-tumor anthracyclines.Anticancer Drug Des., 5, 30-52 (1990). 

저자의 다른 논문 :

최상운 (101) Kim, Kwang-Hee (2) 이정옥 (47)